Noxopharm’s solution to the biggest challenge in cancer therapy
Immuno-oncology (I-O) cancer medications have seen a big leap forward in the past few decades. Yet they face
Immuno-oncology (I-O) cancer medications have seen a big leap forward in the past few decades. Yet they face
Treat the cause - not the symptoms. It’s an old phrase but Australian drug developer Nyrada (ASX: NYR)
Along with a multitude of other habits of our lives, retail habits have dramatically changed during the pandemic.
For so long, a fixture of Australian life has been working towards the great Australian dream. It may
High Grade Iron Ore Report Part 2. Could Australia ever become an energy superpower without a total reliance
This week we were joined by TZ Limited (ASX: TZL) Chairman Peter Graham for an investor briefing and
Over the last decade, technological improvements and algorithmic learning have made rapid improvements to many facets of people’s